These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31126554)

  • 21. [The "regulating conception-governor vessel" acupuncture method for infertility of polycystic ovarian syndrome].
    Zhuo Y; Wu J; Lin W; Pi M; Chen P; Yang Z
    Zhongguo Zhen Jiu; 2016 Dec; 36(12):1237-1241. PubMed ID: 29231358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acupuncture Treatment of Polycystic Ovarian Syndrome Patients with Abdominal Obesity by Regulating Dai Meridian: A Randomized Controlled Clinical Trial].
    Shen LY; Liang CM; Yang WJ; Pan L; Li H; Hu H
    Zhen Ci Yan Jiu; 2018 Apr; 43(4):255-9. PubMed ID: 29888581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
    Abdel-Maboud M; Menshawy A; Hasabo EA; Abdelraoof MI; Alshandidy M; Eid M; Menshawy E; Outani O; Menshawy A
    PLoS One; 2021; 16(7):e0254412. PubMed ID: 34280195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
    Sahu A; Tripathy P; Mohanty J; Nagy A
    J Gynecol Obstet Hum Reprod; 2019 May; 48(5):335-339. PubMed ID: 30316907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effects of Shou-Wu Jiang-Qi Decoction combined acupuncture on the treatment of Polycystic Ovarian Syndrome with kidney deficiency, phlegm and blood stasisness: Study protocol clinical trial (SPIRIT Compliant).
    Xu W; Tang M; Wang J; Wang L
    Medicine (Baltimore); 2020 Mar; 99(12):e19045. PubMed ID: 32195930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extremely high levels of estradiol and testosterone in a case of polycystic ovarian syndrome. Hormone and clinical similarities with the phenotype of the alpha estrogen receptor null mice.
    Bartolone L; Smedile G; Arcoraci V; Trimarchi F; Benvenga S
    J Endocrinol Invest; 2000; 23(7):467-72. PubMed ID: 11005272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a holistic yoga program on endocrine parameters in adolescents with polycystic ovarian syndrome: a randomized controlled trial.
    Nidhi R; Padmalatha V; Nagarathna R; Amritanshu R
    J Altern Complement Med; 2013 Feb; 19(2):153-60. PubMed ID: 22808940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Balint-Perić L; Puzigaća Z
    Gynecol Endocrinol; 1989 Dec; 3(4):269-80. PubMed ID: 2516704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
    J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the individual curative effect of acupuncture for obese women with polycystic ovary syndrome based on metagenomic analysis: study protocol for a randomized controlled trial.
    Fan H; Hong X; Zeng J; Wang X; Chen J
    Trials; 2021 Jul; 22(1):454. PubMed ID: 34266458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
    Kuek S; Wang WJ; Gui SQ
    Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):965-72. PubMed ID: 21906521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of Acupuncture on Reproductive Endocrine and p-Akt Protein Expression in Polycystic Ovary Syndrome Rats with Insulin Resistance].
    Zhang Y; Cao S; Wen SD; Re ZC; Li YP; Tong L
    Zhen Ci Yan Jiu; 2018 Oct; 43(10):622-6. PubMed ID: 30365256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cyproterone acetate/ethinyl estradiol combination on periodontal status and high-sensitivity C-reactive protein levels in women with polycystic ovary syndrome: a cross-sectional study.
    Singhal R; Tewari S; Sharma R; Singhal S; Tanwar N; Sangwan A
    Quintessence Int; 2024 Apr; 55(4):274-285. PubMed ID: 38391191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and metabolic safety of long-term treatment with ethinyl oestradiol/cyproterone and desogestrel/ethinyl oestradiol tablets in women with polycystic ovary syndrome].
    Zhang J; Su M; Xu L; Yang Z; Yin W; Nie Y; Qiao X; Cheng R; Ma Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):917-922. PubMed ID: 30187872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
    Luboshitzky R; Herer P; Shen-Orr Z
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of ZhuLian's type Ⅱ inhibition needling technique on endocrine metabolism in rats with polycystic ovary syndrome and insulin resistance].
    Huang LL; Zhao XJ; Mai W; He C; Fan YS
    Zhen Ci Yan Jiu; 2022 Feb; 47(2):148-53. PubMed ID: 35218625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
    Chung JP; Yiu AK; Chung TK; Chan SS
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):166-71. PubMed ID: 24656700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.